Cleared Traditional

K051826 - BETACONE HIP PROSTHESIS SYSTEM

K051826 is an FDA 510(k) clearance for BETACONE HIP PROSTHESIS SYSTEM, manufactured by Waldemar Link GmbH & Co. KG. The device is a Class 2 Orthopedic device with product code LWJ cleared through the Traditional 510(k) pathway after a 136-day FDA review.

K051826 · Waldemar Link GmbH & Co. KG · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2005
Decision
136d
Days
Class 2
Risk

K051826 is an FDA 510(k) clearance for the BETACONE HIP PROSTHESIS SYSTEM. Classified as Prosthesis, Hip, Semi-constrained, Metal/polymer, Uncemented (product code LWJ), Class II - Special Controls.

Submitted by Waldemar Link GmbH & Co. KG (Philadelphia, US). The FDA issued a Cleared decision on November 18, 2005 after a review of 136 days - within the typical 510(k) review window.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3360 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Waldemar Link GmbH & Co. KG devices

FDA 510(k) Submission Details - K051826

510(k) Number K051826 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2005
Decision Date November 18, 2005
Days to Decision 136 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
14d slower than avg
Panel avg: 122d · This submission: 136d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

LWJ Device Classification - Class 2, Special Controls

Product Code LWJ Prosthesis, Hip, Semi-constrained, Metal/polymer, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3360
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LWJ Prosthesis, Hip, Semi-constrained, Metal/polymer, Uncemented

All 74
Devices cleared under the same product code (LWJ) and FDA review panel - the closest regulatory comparables to K051826.
U2 HIP STEM, TI PLASMA SPRAY
K062978 · United Orthopedic Corp. · Jan 2007
UNISYN HA PLASMA MODULAR HIP
K062383 · Hayes Medical, Inc. · Dec 2006
EXCIA
K061699 · Aesculap, Inc. · Aug 2006
U2 ACETABULAR COMPONENT
K050262 · United Orthopedic Corp. · Aug 2005
EXCIA TOTAL HIP SYSTEM
K042344 · Aesculap, Inc. · Mar 2005
Z - SERIES MODULAR TOTAL HIP SYSTEM PLASMA COATED
K040685 · Osteoimplant Technology, Inc. · Jan 2005